# Model-informed COVID-19 vaccine prioritization strategies by age and serostatus ###### tags: `articles` [Note of Shen(2022/3/2)](https://hackmd.io/NJRqEdYvQ-mKCSF3914P7w?both) ## Introduction Compare the impact of different COVID-19 vaccine prioritization strategies <!--- with variation in 3 areas Variations: 1. Variation in performance of the vaccine (vaccine efficacy) 2. Variation in infection and fatality rate by age 3. Variation in age distribution, age stratified contact rate. ---> There are two main approaches to vaccine prioritization: 1. vaccinate those at highest risk for severe outcomes 2. vaccinate those who do the most transmitting ## Details of the Model - SEIR model: [Supplement material](https://hackmd.io/@xxoooxx345678/Syo2iyDxK) - Input - **strategy** - age-dependent contact matrix - susceptibility to infection rate - infection fatality rate - infectious period - latent period - $R_0$ - vaccine efficacy - ... - Output (Performance of the strategy) - cumulative incidence of infections - mortality - years of life lost (YLL) ## Impacts of vaccine prioritization strategies on mortality and infectious `Vaccines with 90% efficacy, 0.2% rollout/day` - Prioritizations 1. under 20 2. adults between ages $20$ and $49$ years 3. adults $20$ years or older 4. adults $60$ years old or older 5. all individuals ![](https://i.imgur.com/vwEqAGO.png) Scenario 1: $R_0=1.15$ Scenario 2: $R_0=1.5$ ![](https://i.imgur.com/j9cJKLN.png) ## Impact of transmission rates, age demographics, and contact structure `Vaccines with 90% efficacy` ![](https://i.imgur.com/6rNOhw5.png) ## Variation in vaccine efficacy by age ![](https://i.imgur.com/wExHLYO.png) scenario 1: $R_0=1.15$ scenario 2: $R_0=1.5$ ![](https://i.imgur.com/RupMEDK.png) ## Incorporation of population seroprevalence and individual serological testing `Vaccines with 90% efficacy, 0.2% rollout/day` $R_0=1.5$ ![](https://i.imgur.com/ueGHn3k.png) ## Supplement ### More Complicated Model Considering - vaccine hesitancy - pre-transmission rollout - variable rollout rate - imperfect serological tests - ... ### Impact of vaccine efficacy scenario 1: 0.2% rollout/day, $R_0=1.15$ scenario 2: 0.2% rollout/day, $R_0=1.5$ scenario 3: pre-transmission vaccination, $R_0=1.5$ scenario 4: pre-transmission vaccination, $R_0=2.6$ > $R_0$ of the delta variant is 5~8 ![](https://i.imgur.com/I7XdGrd.png) ### Impact of rollout speed ![](https://i.imgur.com/lu6dsLg.png)